Porphyric neuropathy: prevention of progression using haeme-arginate.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8258754.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report on a patient with acute intermittent porphyria (AIP) who, during treatment with hypertonic glucose, developed peripheral neuropathy. Once haeme-arginate was started, the progression of the neuropathy was attenuated. This suggests that hypertonic glucose may be inadequate in preventing the development of neuropathy in a patient with porphyria. However, haeme-arginate, if started early, can attenuate the progression of porphyric neuropathy.
Medical subject headings
- Arginine
- Heme
- Peripheral Nervous System Diseases
- Porphyria, Acute Intermittent